Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter, Randomized, Double-Masked, Parallel-Arm Phase 2b Study Evaluating the Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension
Conditions
Interventions
OTX-TP
Timolol
Locations
1
United States
Vold Vision
Fayetteville, Arkansas, United States
Start Date
November 1, 2014
Primary Completion Date
September 1, 2015
Completion Date
December 1, 2015
Last Updated
December 14, 2016
NCT07539675
NCT06289491
NCT07496957
NCT04354545
NCT07298356
NCT07075718
Lead Sponsor
Ocular Therapeutix, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions